Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination The Road towards Triple Agonists: Glucagon Like Peptide 1, Glucose Dependent Insulinotropic Polypeptide and Glucagon Receptor An Update What is the pipeline for future medications for obesity? International Journal of Obesity The Influence of Glucagon like Peptide 1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link